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Special Article

Electrophysiology Practice During COVID-19
Pandemic: A New York Tertiary Hospital Experience
Diana Anca, MD*,1, Olivia Reyesy, Raman Lala Mitra, MDy,2,
Laurence Mark Epstein, MDy,2,
Linda Shore-Lesserson, MD, FAHA, FASEy,3
*

Weill Cornell Medicine, New York, NY
Zucker School of Medicine at Hofstra, Hempstead, NY

y

As hospitals became overwhelmed during the Covid-19 pandemic in March-May in New York, Cardiology and Electrophysiology (EP) departments rapidly developed protocols for case selection as well modifying the practice of managing the cases. Recommendations by the AHA/HRS
as well as American Society of Anesthesiology (ASA) were considered in the multidisciplinary collaborative approach to patient care and personnel safety and the anesthesiology team had an integral role in developing protocols for workflow, care, recovery and transport during these
challenging times.
Ó 2020 Elsevier Inc. All rights reserved.
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THE SEVERE acute respiratory syndrome coronavirus 2
(SARS-CoV-2), which originated in Wuhan, China, in the last
quarter of 2019, is now a global pandemic, affecting all aspects
of life. The United States has been affected significantly by
this global crisis, accounting for more than one third of the
world’s cases and being the country with the highest numbers
of cases globally. This has strained the healthcare system and
society, especially in New York State and New York City,
which have been the hardest hit areas thus far.1-3
The disease conferred by SARS-CoV-2, coronavirus disease 2019 (COVID-19), is believed to be predominantly
respiratory in origin, with pneumonia and acute respiratory
distress syndrome being responsible for most critical care
unit patient admissions. The virus causes pulmonary illness
by attaching to the angiotensin-converting enzyme-2 receptor
on respiratory epithelium and entering cells through this
mechanism. Cardiac myocytes and other cells contain
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angiotensin-converting enzyme-2 receptors, and therefore
there are other targets of SARS-CoV-2 and other end-organs
at risk. Indeed, it is now appreciated that a significant number
of cardiac abnormalities and arrhythmias are associated with
COVID-19 disease.1,2,4
Herein, the authors’ experience with their institution’s electrophysiology (EP) service during the fight against COVID-19
at North Shore University Hospital, a “hot-spot” hospital just
outside the city limits of New York City, is discussed. Their
tertiary care center has a complex EP laboratory and an
advanced heart failure and transplantation program.
COVID-19Related Arrhythmias
In a report from Wuhan describing 138 COVID-19 patients,
16 of 36 patients admitted to the intensive care unit (ICU) had
arrhythmias (44.4%).5 A report of 115 patients admitted to the
University of Alabama at Birmingham ICU noted that 19 of
the 115 (16.5%) COVID-19 patients developed an atrial tachycardia that had not been present on admission. These included
12 cases of atrial fibrillation, six cases of atrial flutter, and one
case of atrial tachycardia.6 Atrial tachycardia is the most
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common COVID-19related arrhythmia, but other arrhythmias, such as ventricular tachycardia, torsades de pointes, and
conduction abnormalities, also have been encountered.4,7,8
Many patients have associated myocardial dysfunction, myocarditis,6 septic shock, and systemic inflammation7 and have
demonstrated cardiac arrest rhythms, including pulseless electrical activity and ventricular fibrillation. In addition to direct
myocardial viral involvement, there are other mechanistic
explanations for the large incidence of arrhythmias in this population. The prothrombotic state induced by severe SARSCoV-2 infection can cause coronary ischemia, left ventricular
dysfunction, cardiogenic shock, and pulmonary emboli, with
resultant right ventricular dysfunction, all of which can manifest arrhythmias.9,10 The direct effects of hypoxia and electrolyte disturbances and the effects of QT-prolonging
medications can predispose to the development of arrhythmias.9,10 In addition, the medications specifically used for
treatment of COVID-19, such as hydroxychloroquine, chloroquine, and azithromycin, are known to prolong the QT interval
and may lead to fatal ventricular arrhythmias.11
EP Procedures During the Pandemic
As the outbreak of COVID-19 overwhelmed the practice of
medicine, hospitals and healthcare systems formed task forces
to address the management of procedures and allocation of
resources, equipment, and staffing. In general, the important
role of the electrophysiologist in cardiac health is primary
because 40% of cardiology encounters are arrhythmia-related.
A similar incidence of electrophysiologic disease has been
reported during the COVID-19 pandemic.
Teamwork is essential because the electrophysiologist
might be called to address the arrhythmias in coordination
with primary care, ICU, cardiology, and anesthesia teams for
any patient who needs urgent, emergency, or semi-urgent EP
procedures. In the authors’ institution, the task force that was
formed to guide procedures in the EP/catheterization laboratory worked in conjunction with hospital administration, the
anesthesia department, and engineering and transportation
departments, as well as providers, to determine the steps and
workflow required to ensure appropriate isolation of COVID19positive patients or persons under investigation.
To care for patients with EP disturbances during the crisis,
the Heart Rhythm Society (HRS) COVID-19 Rapid Response
Task Force, in conjunction with the American College of Cardiology (ACC) Electrophysiology Council, and American
Heart Association (AHA) Council on Clinical Cardiology
released a joint statement to provide guidance for the management of patients with COVID-19related arrhythmias.12 The
statement addressed the management of invasive and noninvasive procedures, with attention paid to the importance of triage
and the potential exposure risk to patients, healthcare providers, and industry representatives.12,13
The HRS/ACC/AHA statement described the triage of procedures into three categories. Urgent or emergency procedures
should not be postponed, semi-urgent procedures are prioritized based on clinical characteristics and health system

resources, and non-urgent or elective procedures should be
postponed. The HRS/ACC/AHA recommendation to postpone
or cancel non-urgent procedures was based on federal and state
executive orders and the strain on hospital systems that were
diverting all resources to care for COVID-19 patients
(Table 1).12,13
For persons under investigation for COVID-19related illness, HRS/ACC recommended waiting for the viral infection
test result so that equipment and resources could be conserved
judiciously. The HRS/ACC guidance document also placed
increased emphasis on the use of telemedicine, digital health,
and remote device monitoring because these underutilized programs can prove to be highly effective methods of monitoring.
Anesthetic Considerations for EP Procedures During
COVID-19 Pandemic
Anesthesiologists are well-suited to be an integral part of the
management of care for patients undergoing EP procedures
during the COVID-19 crisis. Anesthesiologists provide specific consultation, provide appropriate anesthetic management,
and coordinate the efforts of the involved teams in order to
ensure the safest approach. Consideration is given to the prioritization of procedures, work environment, anesthetic technique, airway management, and anesthesia equipment
cleaning and maintenance.14
Because of the highly contagious nature of SARS-CoV-2,
transmission by asymptomatic carriers, and a significant false
negative rate in diagnostic testing, it might be challenging to
accurately identify and isolate all COVID-19 patients. Thus,
the American Society of Anesthesiologists (ASA) recommends an escalation of standard practice during airway management for all patients, using rapid-sequence induction and
minimization of positive-pressure ventilation as routine to
minimize the potential for aerosolization of droplets. Fiberoptic intubations should be avoided unless absolutely necessary.14-18
Management of Cardiac Implantable Electronic Devices
The HRS COVID-19 Rapid Response Task Force published
guidance for healthcare providers for the management of
patients with cardiac implantable electronic devices (CIEDs),
Table 1
HRS/ACC/AHA Recommendations
Triage

Urgent/emergency
Semi-urgent
Non-urgent/elective

PUI
Visits/monitoring

Should not be postponed
Prioritized on clinical characteristics and
resources
Should be cancelled/postponed
Wait for the viral test result to conserve/
manage resources
Telemedicine, digital health, remote-device
monitoring

Abbreviations: ACC, American College of Cardiology; AHA, American Heart
Association; HRS, Heart Rhythm Society; PUI, Person Under Investigation
Adapted from the Heart Rhythm Society.12
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with an emphasis on limiting exposure to both patients and
clinicians.19,20
All outpatient monitoring should be done remotely when
possible. For inpatient or emergency room management, preliminary discussion should be performed via phone or telehealth consultation. Interrogation of the device should be
performed only if will affect patient care. Routine device interrogation should be avoided, and “in-hospital” remote monitoring technology should be used if necessary. The HRS task
force discourages routine checks for CIED evaluation and preoperative CIED interrogation if a patient is not pacemakerdependent. Routine evaluation for magnetic resonance imaging for patients with loop recorders also is discouraged.
In the perioperative period, rather than interrogation, magnet placement is encouraged for suspending antitachycardia
therapies in patients with defibrillators and in pacemakerdependent patients when electromagnetic interference is
expected. Dedicated remote interrogation devices with cellular
and internet connections strongly are encouraged.19,20
Device interrogation only would be prioritized for the following logistic scenarios: suspected device malfunction (inappropriate pacing or shocking), suspected elective replacement
interval, preoperative evaluation if no interrogation within six
months, and urgent/emergency magnetic resonance imaging
evaluation. Direct interrogation also may be prioritized for the
clinical conditions of syncope, untreated tachycardia, and
stroke etiology.19,20 All interrogation equipment should be
cleaned with disinfecting wipes after each use (Table 2).
Personnel
Both the Centers for Disease Control and Prevention and the
Occupational Safety and Health Administration have published guidelines for personal protective equipment (PPE) and
its use.21,22
The ASA has offered specific guidance for provider protection during anesthetic management, including endotracheal
intubation and equipment recommendations.15-17 The HRS
recommendations include suggested modifications of the management of CIEDs in order to minimize personnel
exposure.19,20
Institution Experience
In the authors’ tertiary cardiovascular center, from March 16
to May 16, there were 115 cases operformed, procedures in
Electrophysiology Suite, excluding five implantable loop
recorders. These included 60 device implantations and generator replacements, 21 catheter ablations, 10 device lead extractions, and 24 cardioversions. Among the catheter ablations,
eight were for ventricular tachycardia and 13 were for either
atrial fibrillation, atrial flutter, or supraventricular tachycardia
(Table 3).
During the same interval in 2019 there were 426 cases procedures in EP Suite and 106 loop recorders were implanted.
The triage of procedures was implemented by the authors’
institution as soon the ACC/AHA and HRS guidelines were
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Table 2
HRS Task Force Management of CIEDs of Inpatients/Emergency Department
Preliminary discussion/consultation over the phone
Discourages
 Routine CIED interrogation
 Preoperative interrogation for non-pacerdependent patients
 Routine evaluation for MRI planning for patient with ILR
Encourages
 Magnet placement for suspension of antitachyarrhythmias
 Therapy and asynchronous pacing in pacer-dependent patients
 Dedicated interrogation devices
 Remote interrogation devices
Prioritize device interrogation
 Suspected device malfunction (inappropriate pacing or shocking)
 Suspected ERI
 Preoperative interrogation if no evaluation within 6 mo
 Urgent/emergency MRI evaluation
 Syncope, untreated tachycardia, stroke etiology
Equipment cleaning
 Disinfecting wipes after each use
Abbreviations: CIED, cardiac implantable electronic devices; ED,; ERI,
elective replacement interval; HRS, Heart Rhythm Society; ILR, implantable
loop recorder; MRI, magnetic resonance imaging.

published. The determination of urgent, semi-urgent or semielective, and elective was made by the EP team in collaboration with the primary or ICU team for inpatients or the primary
care physician for outpatients. Most procedures were urgent
and semi-urgent (eg, device implantations or replacements for
diagnoses such as syncope, high-degree atrioventricular block,
or replacement interval indications). Urgent and semi-urgent
lead extractions were performed for infection or malfunction,
and cardioversions and catheter ablations were scheduled for
symptomatic arrhythmias refractory to medical treatment.
Only two patients were known to be COVID-19-positive at
the time of their procedure, and 71 patients had negative
results. The remaining 42 patients presented early during the
pandemic when there was a relative paucity of COVID-19 testing available and unreliable rapid testing. The urgency of the
procedure dictated whether a procedure was performed before
a COVID-19 test result could be returned. The authors’ hospital developed protocols for testing and procedural management
Table 3
NSUH Experience
Sex
Status
COVID-19 status

Procedures

Female
Male
Inpatient
Outpatient
Positive
Negative
N/A
Device implantation/generator change
Catheter ablation
Atrial fibrillation/flutter
VT
Cardioversions
Lead extractions

Abbreviations: COVID-19, coronavirus disease 2019; NSUH, Northshore
University Hospital; VT, ventricular tachycardia.

41
74
46
69
2
71
42
60
21
13
8
24
10
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and dictated that all patients who did not have a COVID-19
test result would be treated as if they were positive.
There were six fatalities, for a death rate of 5%, which was
much higher than the institution’s usual mortality rate in the
EP service. Two of the fatalities were COVID-19-positive.
One patient, who had a leadless pacemaker, died of sepsis.
The second patient, who had a dual-chamber pacemaker, died
of cardiogenic shock as a result of extensive coronary thrombosis, which was believed to be COVID-19 related. The other
four fatalities occurred after discharge, and the causes of death
are unclear, but the patients were COVID-19 negative.
Fortunately, the EP laboratory is located within the catheterization suite, which enabled the creation of a procedure room
that would serve COVID-19 patients for both EP and coronary
catheterization procedures. The assigned procedure room was
confirmed to have negative-pressure ventilation, and high-efficiency particulate air filters were present on the anesthesia
machine. The room was emptied of any redundant or unnecessary equipment, and a clean, isolated storage area in the adjacent monitoring room was delineated with zippered plastic
curtains. Nearby in the suite, a specific soiled utility and a
decontamination room were assigned. Another procedure
room was repurposed and converted to a preoperative holding
and recovery area for both the EP and catheterization laboratory, because these usual units had to be transformed into
COVID-19 ICUs during the surge. Written protocols for care
were developed in accordance with the HRS guidelines, and
elevators and routes of transport were assigned for COVID-19
patients. The anesthesiology department generated videos
detailing the proper procedure for donning and doffing of PPE
while always ensuring that there was adequate supply to maintain the safety of staff (Table 4).
Clinically, the daily huddle addressed each case individually
to review indications and the protocol to be followed. Outpatients who were scheduled for semi-urgent or urgent procedures were screened for COVID-19 viral antigen before being
admitted to the hospital.
For the COVID-19positive inpatients, consent for anesthesia services was obtained telephonically, and a full report on
the patient was communicated before transport was activated.
At the procedure room, all personnel entering the room donned
PPE before entering the room and doffed inside the room
immediately before exiting. At the conclusion of the procedure, the patient either recovered in the procedure room with a
post-anesthesia care unit nurse or was transported directly to a
COVID-19 ICU. After recovery in the procedure room, the
patient was transferred to a COVID-19specific floor.
The anesthetic technique used for each case was discussed
with the proceduralist and the patient, taking into consideration
the patient’s symptoms, the common anesthetic technique that
would have been used before the pandemic, and the risk of
aerosolization associated with that particular airway management.
For device implantations in COVID-negative or undetermined patients, sedation using midazolam with fentanyl or a
propofol infusion was used. For patients requiring general
anesthesia with endotracheal intubation, a rapid-sequence

Table 4
Institution Protocols/Changes
Creation of a COVID-19 procedure room with negative pressure ventilation
HEPA filters on anesthesia machines
Removed redundant/unnecessary equipment
Monitoring room: clean, isolated by zippered plastic curtains
Designated soiled utility/decontamination room
Repurposing of a procedure room as recovery room
Recovering COVID-19 patients in the procedure room
Established specific routes and elevators for COVID-19 patients
PPE donning and doffing instructional videos
Abbreviations: COVID-19, coronavirus disease 2019; HEPA, high-efficiency
particulate air; PPE, personal protective equipment.

induction with the use of video laryngoscope was used in
alignment with the ASA recommendations. Whenever possible, deep extubation was used to minimize aerosolization.
For the two known COVID-19positive patients, monitored
anesthesia care was used, with very light sedation (1 mg midazolam and 50 mg fentanyl), with an oxygen mask instead of
nasal cannula, in order to cover both the mouth and nose. A
surgical mask was placed on top of the oxygen delivery mask.
For perioperative management of patients with CIEDs, the
HRS recommendations were followed and device interrogation
related to perioperative management was performed remotely,
as is routinely done for outpatient interrogation. In-person
interrogation was performed rarely and only for emergency situations, such as preoperative interrogation, in which case, a
designated device was used and was disinfected after each use.
In the epicenter of this major pandemic, the institution had
redeployed staff to cover the ICUs and emergency room. As
such, some of the nursing and technology staff were reassigned
to the COVID-19 units, and some of the electrophysiologists
were deployed as back-up consultants. Given the fact that only
urgent and semi-urgent procedures were performed, the EP
laboratory had a reduced schedule volume and functioned very
efficiently despite a skeleton staff. Communication preoperatively and at the morning huddle was critical to implementing
a plan that was appropriate for the patient, the personnel, and
the procedure and recovery periods.
Conclusions
The current pandemic has challenged the delivery of routine
and emergency care worldwide and has forced changes to
ensure the safety of patients and healthcare personnel.
EP laboratories in the hot spot areas, with a significant number of COVID-19positive patients, have had to adapt. The
authors did this by limiting cases to urgent and semi-urgent
according to HRS guidelines, modifying the procedure areas
and recovery areas to accommodate COVID-19positive
patients, altering cleaning and disinfecting areas, and adopting
a more proactive approach through telemedicine in order to
limit personnel and equipment exposure.
Anesthesiologists are a critical part of the EP team, often
functioning as a central communication resource for care and
clinical processes. This is especially applicable to the care of
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patients during the COVID-19 pandemic. In addition to navigating the anesthesia and airway challenges, the coordination
of care according to the recent HRS recommendations and
establishing workplace safety protocols are prime roles for the
anesthesiology consultant.
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